Bayer Announces Publication of Health Economic Model Evaluation at RSNA, Providing New Insights Into Cost Effectiveness and Capacity Needs of Supplemental Screening Modalities for Dense BreastsBusiness Wire • 11/27/23
Bayer Championing Advancements in Radiology Pipeline and Accelerating AI InnovationBusiness Wire • 11/22/23
Bayer shares plunge to a near two-decade low after blood thinner trial failureProactive Investors • 11/20/23
Bayer shares plunge by more than 20% after trial of potential blockbuster drug haltedMarket Watch • 11/20/23
Forrest Weldon Law Group Delivers Justice With $1.56 Billion Victory in Bayer Roundup TrialBusiness Wire • 11/19/23
Bayer Issues Voluntary Recall Nationwide of VITRAKVI® (larotrectinib) Oral Solution 20 mg/mL Due to Presence of Microbial ContaminationBusiness Wire • 11/17/23
Bayer vows to cut ‘multiple layers of management' by end of 2024 as new CEO says firm's performance is ‘not acceptable'Market Watch • 11/08/23